Irreversible Eye Damage from Interferon Therapy
Author Information
Author(s): Seddik Hassan, Tamzaourte Mouna, Rouibaa Fadoua, Fadlouallah Maha, Benkirane Ahmed
Primary Institution: Mohamed V Military Hospital, Rabat, Morocco
Hypothesis
Can interferon alpha and ribavirin therapy lead to irreversible anterior ischemic optic neuropathy in patients with chronic hepatitis C?
Conclusion
The study reports a case of irreversible anterior ischemic optic neuropathy as a complication of interferon therapy for chronic hepatitis C.
Supporting Evidence
- Ophthalmologic complications with interferon therapy are rare and usually reversible.
- The patient developed irreversible anterior ischemic optic neuropathy during treatment.
- Visual acuity did not improve significantly after treatment was stopped.
Takeaway
This study shows that a patient treated for hepatitis C with interferon therapy had serious eye problems that didn't get better, which is unusual.
Methodology
Case report of a patient undergoing interferon and ribavirin therapy for chronic hepatitis C.
Limitations
The findings are based on a single case report, limiting generalizability.
Participant Demographics
A 55-year-old man with chronic hepatitis C.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website